SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-19-008019
Filing Date
2019-04-30
Accepted
2019-04-30 16:11:42
Documents
5
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10001356x2_defa14a.htm DEFA14A 23062
2 nc10001356x2_proxycard1.jpg GRAPHIC 124748
3 nc10001356x2_proxycard2.jpg GRAPHIC 202929
4 nc10001356x2_proxycard3.jpg GRAPHIC 62739
5 nc10001356x2_proxycard4.jpg GRAPHIC 8326
  Complete submission text file 0001140361-19-008019.txt   563853
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36829 | Film No.: 19781818
SIC: 2834 Pharmaceutical Preparations